Hepatocellular carcinoma (HCC) ranks second in cancer-related death and its incidence is increasing worldwide. Papain is a proteolytic enzyme and a potential anticancer agent. The aim of the study is to evaluate the cytotoxic effect of papain in human hepatoma HepG2 cell line through apoptosis. The cytotoxicity of papain was determined by the MTT method. Morphological changes of Papain-treated HepG2 cells were evaluated by acridine orange and ethidium bromide (AO/EB) dual staining. Apoptotic activity was determined by the expression of apoptosis regulator caspase-3 and caspase-9 genes by qPCR method. As a result of the administration of 500 µg/ml, 250 µg/ml, 100 µg/ml, 50 µg/ml, 25 µg/ml and 10 µg/ml papain to HepG2 cells for 48 hours, the IC50 value was found to be 53 µg/ml. Caspase 3 and 9 gene expressions, which are apoptotic markers, were significantly increased as a result of papain administration in HepG2 cells. In conclusion, papain may have anticancer effect for HCC treatment by inducing expression of apoptosis regulatory genes.
Papain; HepG2; Hepatocellular carcinoma; Cytotoxicity; Apoptosis.
Birincil Dil | Türkçe |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | ORİJİNAL MAKALELER / ORIGINAL ARTICLES |
Yazarlar | |
Yayımlanma Tarihi | 23 Ocak 2023 |
Yayımlandığı Sayı | Yıl 2023 Cilt: 45 Sayı: 1 |